Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 4
1960 1
1965 2
1967 1
1968 6
1969 5
1970 2
1971 6
1972 5
1973 3
1975 5
1976 2
1978 4
1980 10
1981 16
1982 8
1983 7
1984 6
1985 8
1986 9
1987 6
1988 18
1989 19
1990 14
1991 20
1992 18
1993 21
1994 22
1995 25
1996 21
1997 19
1998 19
1999 23
2000 22
2001 26
2002 37
2003 32
2004 46
2005 38
2006 42
2007 48
2008 53
2009 41
2010 42
2011 74
2012 77
2013 79
2014 80
2015 102
2016 85
2017 101
2018 98
2019 115
2020 147
2021 143
2022 146
2023 110
2024 36

Text availability

Article attribute

Article type

Publication date

Search Results

1,903 results

Results by year

Filters applied: . Clear all
Page 1
The ILAE consensus classification of focal cortical dysplasia: An update proposed by an ad hoc task force of the ILAE diagnostic methods commission.
Najm I, Lal D, Alonso Vanegas M, Cendes F, Lopes-Cendes I, Palmini A, Paglioli E, Sarnat HB, Walsh CA, Wiebe S, Aronica E, Baulac S, Coras R, Kobow K, Cross JH, Garbelli R, Holthausen H, Rössler K, Thom M, El-Osta A, Lee JH, Miyata H, Guerrini R, Piao YS, Zhou D, Blümcke I. Najm I, et al. Among authors: miyata h. Epilepsia. 2022 Aug;63(8):1899-1919. doi: 10.1111/epi.17301. Epub 2022 Jun 15. Epilepsia. 2022. PMID: 35706131 Free PMC article.
Celastrol suppresses humoral immune responses and autoimmunity by targeting the COMMD3/8 complex.
Shirai T, Nakai A, Ando E, Fujimoto J, Leach S, Arimori T, Higo D, van Eerden FJ, Tulyeu J, Liu YC, Okuzaki D, Murayama MA, Miyata H, Nunomura K, Lin B, Tani A, Kumanogoh A, Ikawa M, Wing JB, Standley DM, Takagi J, Suzuki K. Shirai T, et al. Among authors: miyata h. Sci Immunol. 2023 Mar 31;8(81):eadc9324. doi: 10.1126/sciimmunol.adc9324. Epub 2023 Mar 31. Sci Immunol. 2023. PMID: 37000855
Exploring the Multifaceted Nexus of Uric Acid and Health: A Review of Recent Studies on Diverse Diseases.
Kuwabara M, Fukuuchi T, Aoki Y, Mizuta E, Ouchi M, Kurajoh M, Maruhashi T, Tanaka A, Morikawa N, Nishimiya K, Akashi N, Tanaka Y, Otani N, Morita M, Miyata H, Takada T, Tsutani H, Ogino K, Ichida K, Hisatome I, Abe K. Kuwabara M, et al. Among authors: miyata h. Biomolecules. 2023 Oct 13;13(10):1519. doi: 10.3390/biom13101519. Biomolecules. 2023. PMID: 37892201 Free PMC article. Review.
Density and maturity of peritumoral tertiary lymphoid structures in oesophageal squamous cell carcinoma predicts patient survival and response to immune checkpoint inhibitors.
Hayashi Y, Makino T, Sato E, Ohshima K, Nogi Y, Kanemura T, Honma K, Yamashita K, Saito T, Tanaka K, Yamamoto K, Takahashi T, Kurokawa Y, Miyata H, Nakajima K, Wada H, Morii E, Eguchi H, Doki Y. Hayashi Y, et al. Among authors: miyata h. Br J Cancer. 2023 Jun;128(12):2175-2185. doi: 10.1038/s41416-023-02235-9. Epub 2023 Apr 4. Br J Cancer. 2023. PMID: 37016103 Free PMC article.
Chemoradiotherapy versus triplet chemotherapy as initial therapy for T4b esophageal cancer: survival results from a multicenter randomized Phase 2 trial.
Yamasaki M, Miyata H, Yamashita K, Hamakawa T, Tanaka K, Sugimura K, Makino T, Takeno A, Shiraishi O, Motoori M, Kimura Y, Hirao M, Fujitani K, Yasuda T, Yano M, Eguchi H, Doki Y. Yamasaki M, et al. Among authors: miyata h. Br J Cancer. 2023 Jul;129(1):54-60. doi: 10.1038/s41416-023-02286-y. Epub 2023 May 4. Br J Cancer. 2023. PMID: 37142731 Clinical Trial.
The pathogenic role of the BRCA2 c.7847C>T (p.Ser2616Phe) variant in breast and ovarian cancer predisposition.
Yamazawa K, Sugano K, Tanakaya K, Inoue S, Murakami H, Nakashima M, Adachi M, Oki S, Makabe T, Yamashita H, Ueki A, Sasaoka A, Nakashoji A, Kinoshita T, Matsunaga T, Arai M, Nakamura S, Miyata H, Ikegami M, Mano H, Kohsaka S, Matsui A. Yamazawa K, et al. Among authors: miyata h. Cancer Sci. 2023 Jul;114(7):2993-3002. doi: 10.1111/cas.15799. Epub 2023 Apr 17. Cancer Sci. 2023. PMID: 37067535 Free PMC article.
In vitro hair follicle growth model for drug testing.
Kageyama T, Miyata H, Seo J, Nanmo A, Fukuda J. Kageyama T, et al. Among authors: miyata h. Sci Rep. 2023 Mar 24;13(1):4847. doi: 10.1038/s41598-023-31842-y. Sci Rep. 2023. PMID: 36964149 Free PMC article.
Comprehensive registry of esophageal cancer in Japan, 2015.
Watanabe M, Toh Y, Ishihara R, Kono K, Matsubara H, Miyazaki T, Morita M, Murakami K, Muro K, Numasaki H, Oyama T, Saeki H, Tanaka K, Tsushima T, Ueno M, Uno T, Yoshio T, Usune S, Takahashi A, Miyata H; Registration Committee for Esophageal Cancer of the Japan Esophageal Society. Watanabe M, et al. Among authors: miyata h. Esophagus. 2023 Jan;20(1):1-28. doi: 10.1007/s10388-022-00950-5. Epub 2022 Sep 24. Esophagus. 2023. PMID: 36152081 Free PMC article.
Gut microbiota associated with the mitigation effect of synbiotics on adverse events of neoadjuvant chemotherapy in patients with esophageal cancer: A retrospective exploratory study.
Sugimoto T, Atobe S, Kado Y, Takahashi A, Motoori M, Sugimura K, Miyata H, Yano M, Tanaka K, Doki Y, Shiraishi O, Yasuda T, Asahara T. Sugimoto T, et al. Among authors: miyata h. J Med Microbiol. 2023 Jun;72(6). doi: 10.1099/jmm.0.001723. J Med Microbiol. 2023. PMID: 37367942 Clinical Trial.
1,903 results